Metabolic syndrome and its components have been widely considered to be correlated with the initiation and progression of breast cancer, which is due to obesity and its related adipokines, insulin and IGFs, abnormal serum lipids and lipoproteins and the molecules leading to hypertension. The gene discussed is INS; the disease is breast carcinoma.